News & Stories

  In a world still grappling with the aftermath of the COVID-19 pandemic, health disparities are widening and healthcare worker shortages persist, revealing vulnerabilities in our health systems. “Yet within all these challenges lie immense opportunities for collaboration and innovation,” noted Professor Nancy IP, President of The Hong Kong University of Science and Technology (HKUST), at the 2025 Asia Summit on Global Health. As a keynote panelist, she asserted that universities can play a pivotal role in shaping a more equitable and sustainable health system. 

The Hong Kong University of Science and Technology (HKUST) has emerged as the top-performing local institution in the second round of the Innovation and Technology Commission’s (ITC) Research, Academic and Industry Sectors One-plus (RAISe+) Scheme, securing funding for seven projects. Spanning health and medical sciences, artificial intelligence (AI) and robotics, advanced manufacturing, and electrical and electronic engineering, these projects underscore HKUST’s leadership in transforming pioneering research into real-world applications.

The Hong Kong University of Science and Technology (HKUST) announced today that  its School of Engineering researchers have developed Mixture of Modality Experts (MOME), a groundbreaking large artificial intelligence (AI) model for non-invasive breast cancer diagnosis. Trained on the China’s largest multiparametric MRI (mpMRI) breast cancer dataset, MOME achieves expert-level accuracy in classifying tumor malignancy, comparable to that of radiologists with five+years of experience. This innovative solution is now undergoing extensive clinical validation across more than ten hospitals and partner institutions, including Shenzhen People’s Hospital, the Guangzhou First Municipal People's Hospital, and Yunnan Cancer Center, to validate its effectiveness and ensure real-world applicability. Harnesses China’s largest mpMRI Dataset

A Hong Kong University of Science and Technology (HKUST) research team led by Prof. SUN Jianwei and Prof. LIN Zhenyang from the Department of Chemistry has developed a catalytic enantioselective type II [5 + 2] cycloaddition method to address the challenges of synthesizing chiral bridged polycyclic structures, particularly those with a bridged seven-membered subunit. This innovative approach utilizes 3-oxidopyrylium ylides to create the desired complex shapes, paving the way for more applications in the rapid synthesis and diversification of other valuable complex molecules, including important natural products and drug molecules. Chiral bridged polycyclic structures, particularly those bearing a bridged seven-membered subunit, represent a complex and intriguing molecular architecture found in many natural and biologically significant compounds. However, synthesizing these structures has posed substantial challenges for chemists.

The Hong Kong University of Science and Technology (HKUST) has signed a Memorandum of Understanding (MOU) with Tung Wah College (TWC) to enhance collaboration in cross-disciplinary medical education, innovative research, knowledge transfer, and community outreach services. A Synergy of StrengthsCombining HKUST’s strengths in scientific innovation and TWC’s expertise in nurturing high-caliber talent across healthcare disciplines, including nursing and allied health, this partnership focuses on five key areas: 

The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today.  As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for hundreds of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.  

Two healthtech innovators nurtured by The Hong Kong University of Science and Technology (HKUST) - PanopticAI Limited (PanopticAI) and SmartCare Technology Co Limited (SmartCare), have entered a landmark collaboration with Gleneagles Hospital Hong Kong (Gleneagles). Witnessed by Prof. Nancy IP, President of HKUST; Dr. Prem Kumar NAIR, Group Chief Executive Officer of IHH Healthcare; and Dr. Patrick LAU, Deputy Executive Director of Hong Kong Trade Development Council (HKTDC), the tripartite collaboration agreement signing marks a strategic effort to deploy AI-powered smart clinic solutions at Gleneagles MediCentre, set to launch in late 2025. The partnership exemplifies the commitment of both HKUST and Gleneagles to translating research excellence into real-world applications with a view to facilitating healthcare advancements through the University’s robust entrepreneurship ecosystem.

The clatter of dim sum carts filled a transformed teahouse at The Hong Kong University of Science and Technology (HKUST) today, as over 100 participants, including seniors with swallowing difficulties and their families, savored a nostalgic Yum Cha experience on campus. Led by HKUST senior management and distinguished guests, students and staff volunteers served delicate soft-textured and fresh options dim sum on traditional carts, while two HKUST startups showcased how technology could enhance the quality of life for the elderly.